Cartan Capital

Cartan Capital is a US-based investor with a public footprint that suggests a generalist private capital posture — a website, LinkedIn presence, and Crunchbase profile, but limited disclosure of thesis specifics, fund size, or healthcare focus. For healthcare AI founders, treat Cartan as a generalist fund or family-office-style investor whose mandate alignment is unclear without direct conversation. Plausible check size is $250K to $2M based on typical small private-capital economics. Stage focus is most plausibly seed through Series A. Founders who should approach: those with a warm introduction to Cartan and a software-shaped healthcare business that can be evaluated using SaaS-style diligence frameworks — RCM, scheduling, payer ops, ambient documentation, and provider workflow — where domain expertise matters less than execution metrics. Founders who should not approach: regulated medical devices, biotech, and any team requiring a specialist healthcare lead, since Cartan cannot credibly anchor that journey. The realistic entry path is warm introduction through their existing portfolio or through a co-investor in their network. Cold outbound through their website or LinkedIn is feasible but lower-yield. Before investing significant fundraising time, ask the introducer specifically whether Cartan has done healthcare deals, what stage they typically lead or follow at, and what their typical check size is — these answers will determine whether the conversation is worth pursuing. Treat Cartan as round-completion capital alongside a domain-specialist lead rather than as a strategic anchor for a healthcare-specific journey.